National Key Research and Development Program of China [2022YFC2601800]; National Natural Science Foundation of China [32161143017, 82173833, 82173126, 82372743, 81973343]; Guangdong Basic and Applied Basic Research Foundation [2023B1515040006, 2022A1515011632]; Science and Technology Planning Project of Guangdong Province, China [2022A0505050065, SZBL202009051006]; Guangdong Provincial Key Laboratory of Construction Foundation [2023B1212060022]
第一作者机构：[1]Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Tao Lijun,Lu Yunqing,Chen Zhuojia,et al.RNA ac4C modification in cancer biology: from regulatory mechanisms to clinical applications[J].SCIENCE CHINA-LIFE SCIENCES.2024,doi:10.1007/s11427-023-2496-5.
APA：
Tao, Lijun,Lu, Yunqing,Chen, Zhuojia,Ge, Lichen,He, Junming...&Wang, Hongsheng.(2024).RNA ac4C modification in cancer biology: from regulatory mechanisms to clinical applications.SCIENCE CHINA-LIFE SCIENCES,,
MLA：
Tao, Lijun,et al."RNA ac4C modification in cancer biology: from regulatory mechanisms to clinical applications".SCIENCE CHINA-LIFE SCIENCES .(2024)
生物学